Biostability and pharmacokinetics of LJP 920, an octameric Gal (alpha1-3) Gal conjugate for the inhibition of xenotransplantation rejection.
about
Pharmacokinetics of LJP 993, a tetrameric conjugate of domain 1 of beta2-glycoprotein I for antiphospholipid syndromeA novel and rapid LC/MS/MS assay for bioanalysis of Azurin p28 in serum and its pharmacokinetics in micePharmacodynamics and pharmacokinetics of SQ109, a new diamine-based antitubercular drug.The conduct of drug metabolism studies considered good practice (I): analytical systems and in vivo studiesThe conduct of drug metabolism studies considered good practice (II): in vitro experimentsSex-related pharmacokinetic differences and mechanisms of metapristone (RU486 metabolite).
P2860
Biostability and pharmacokinetics of LJP 920, an octameric Gal (alpha1-3) Gal conjugate for the inhibition of xenotransplantation rejection.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Biostability and pharmacokinet ...... xenotransplantation rejection.
@en
Biostability and pharmacokinet ...... xenotransplantation rejection.
@nl
type
label
Biostability and pharmacokinet ...... xenotransplantation rejection.
@en
Biostability and pharmacokinet ...... xenotransplantation rejection.
@nl
prefLabel
Biostability and pharmacokinet ...... xenotransplantation rejection.
@en
Biostability and pharmacokinet ...... xenotransplantation rejection.
@nl
P2093
P2860
P356
P1476
Biostability and pharmacokinet ...... xenotransplantation rejection
@en
P2093
P2860
P304
P356
10.1211/0022357011776243
P50
P577
2001-07-01T00:00:00Z